We also discovered that the level of PPARγ was significantly decreased in the liver tissue of the NAFLD model, while conversely, Nrf2 and PPARα expression were significantly increased. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.